Paradigm Biopharmaceuticals (ASX:PAR) is drawing investor attention this week as its founder and executive chairman, Paul John Rennie, is set to present at the Ignite Investment Summit in Hong Kong.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback